The treatment of Acquired Immunodeficiency Syndrome & Palmar Psoriasis with vitamins

Acquired Immunodeficiency Syndrome and Palmar Psoriasis: Mitamins custom make quality formulas for the treatment of Acquired Immunodeficiency Syndrome & Palmar Psoriasis with vitamins. A Acquired Immunodeficiency Syndrome & Palmar Psoriasis formula will be made to suit you, using quality brand name ingredients. Mitamins produce custom made vitamin and supplement formulas to suit your individual health needs conveniently in one formula, one bottle and one dosage. For assistance, call toll free: 1-866-585-1390
Your Supplements Facts - Covers the formulas above
Supplement Facts

Specially Formulated for: Acquired Immunodeficiency Syndrome and Palmar Psoriasis

  • Amount Per Serving
    % DV
    Vitamin A
    5000
    IU
    100%
    Vitamin C
    500
    mg
    833%
    Vitamin D
    200
    IU
    50%
    Vitamin E
    200
    IU
    667%
    Folate
    400
    mcg
    100%
    Zinc
    10
    mg
    67%
    Copper
    1
    mg
    50%
    CoQ-10
    50
    mg
    *
    Flax Seed Powder
    50
    mg
    *
  • Amount Per Serving
    % DV
    DHEA
    50
    mg
    *
    Omega - 3 Fatty Acids
    1000
    mg
    *
    Maitake Extract
    100
    mg
    *
    Reishi Extract
    100
    mg
    *
    N-Acetyl L-Cysteine
    250
    mg
    *
    Amino Acid Mix
    100
    mg
    *
    Turmeric Extract
    100
    mg
    *
    Bromelain
    250
    mg
    *
    * Daily Value (DV) not established
Name Your Supplement Bottle - Just how you like it
The current default name is: 
 
(Click in box to change)
Your Perfect Supplement - Custom-made just for you
Formulas form 35 Years of Medical Practice
Acquired Immunodeficiency Syndrome and Palmar Psoriasis
Serving Size:4-5

Acquired Immunodeficiency Syndrome and Palmar Psoriasis Formulas Details

Customize Your Supplements - Check all that apply
4A Select additional condition(s) you want to address:


4B Select all the medication(s) you are taking:
If your concern or medication is not listed here, use our Formulator, which covers 680 concerns and 1600 drugs, Click here!
Latest Health Related News:
FDA Approves Osteoporosis Drug to Cut Breast Cancer Risk (HealthDay)
The U.S. Food and Drug Administration on Friday approved the use of the osteoporosis drug Evista for the prevention of invasive breast cancer in certain groups of high-risk women.
First Osteoporosis Study In Patients With Hip Fracture Finds Once-Yearly Aclasta/Reclast Prevents Additional Fractures And Improves Survival
Results of the first ever clinical study in patients with osteoporosis who suffered a hip fracture show that a once-yearly infusion of Aclasta/Reclast (zoledronic acid 5 mg) [*] reduced the risk of subsequent fractures by 35% compared to patients treated with placebo. The study found the risk of death was significantly reduced by 28% in the Aclasta patient group compared to the placebo group (101 vs. 141 deaths).
This information concerning the support of Acquired Immunodeficiency Syndrome and Palmar Psoriasis treatments provide basic knowledge which should always be discussed with your own health practitioner.
Any Questions, Call Us Toll Free: 1-866-585-1390
Live Chat System

manufactured In USA

  verisign          Trust E Finalmark

Custom Vitamins and Nutritional Supplements for Supporting Age-Related Cognitive Decline and Aging Treatments